000 01544 a2200445 4500
005 20250517131458.0
264 0 _c20170627
008 201706s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2016.12.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHill, Matthew D
245 0 0 _aDevelopment of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonists.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_c02 2017
300 _a578-581 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aGuanidine
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aMolecular Structure
650 0 4 _aQuinuclidines
_xchemistry
650 0 4 _aSpiro Compounds
_xchemical synthesis
650 0 4 _aStructure-Activity Relationship
650 0 4 _aalpha7 Nicotinic Acetylcholine Receptor
_xagonists
700 1 _aFang, Haiquan
700 1 _aDigavalli, Sivarao V
700 1 _aHealy, Francine L
700 1 _aGallagher, Lizbeth
700 1 _aPost-Munson, Debra
700 1 _aChen, Ping
700 1 _aNatale, Joanne
700 1 _aBenitex, Yulia
700 1 _aMorgan, Daniel
700 1 _aLodge, Nicholas
700 1 _aBristow, Linda
700 1 _aMacor, John E
700 1 _aOlson, Richard E
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 27
_gno. 3
_gp. 578-581
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2016.12.014
_zAvailable from publisher's website
999 _c26712530
_d26712530